Advertisement

Biochemical Genetics

, Volume 57, Issue 2, pp 222–233 | Cite as

MIR146A rs2910164 (G/C) Polymorphism is Associated with Incidence of Preeclampsia in Gestational Diabetes Patients

  • Dina M. Abo-Elmatty
  • Eman T. MehannaEmail author
Original Article

Abstract

Preeclampsia and gestational diabetes are common pregnancy disorders that may be interrelated. MIR146A rs2910164 (G/C) is a functional polymorphism that was associated with several diseases. This study aimed to investigate the frequency of rs2910164 polymorphism and its possible correlation with the incidence of preeclampsia in gestational diabetes patients. The study involved 250 pregnant women divided into 80 healthy control subjects, 85 gestational diabetes patients only, and 85 patients of gestational diabetes combined with preeclampsia. Systolic and diastolic blood pressures, urinary proteins, kidney and liver functions, glucose homeostasis parameters, and lipid profile were determined. Genotyping of the polymorphism was conducted by PCR-RFLP. The frequency of the minor C allele of rs2910164 polymorphism was significantly higher among patients of gestational diabetes combined with preeclampsia compared to the control group (p = 0.012) and the gestational diabetes group (p = 0.014). Patients of gestational diabetes and preeclampsia carrying CC genotype showed higher systolic and diastolic blood pressure, and increased urea, creatinine, urine protein, and dyslipidemia compared to the carriers of GG and GC genotypes. In conclusion, the results of the current study suggest that the rare CC genotype of MIR146A rs2910164 (G/C) polymorphism may be related to increased incidence of preeclampsia in gestational diabetes patients.

Keywords

Pregnancy Preeclampsia Gestational diabetes MIR146A rs2910164 

Notes

Acknowledgements

The authors are thankful to the staff members of the Obstetrics and Gynecology Department in the Suez Canal University Hospital and tha Ismailia General Hospital for their help in the collection of samples.

Funding

The work was funded by the authors.

Compliance with Ethical Standards

Conflict of interest

The authors declare no conflict of interests.

Informed Consent

All the participants in the study provided written informed consent following a protocol approved by the Research Ethics Committee of Faculty of Pharmacy, Suez Canal University (Code: 201709RH1). The study followed the principles of the Declaration of Helsinki.

References

  1. American Diabetes Association (2017) Classification and diagnosis of diabetes mellitus. Diabetes Care 40(Suppl 1):S11–S24CrossRefGoogle Scholar
  2. Assman TS, Giudice VM, Lima JR, Duarte GCK, Canani LH, Crispim D (2015) RS2910164 polymorphism in the microrna-146a is associated with risk for type 1 diabetes mellitus. Diabetol Metab Syndr 7(Suppl 1):A205CrossRefGoogle Scholar
  3. Bhatt K, Lanting LL, Jia Y, Yadav S, Reddy MA, Magilnick N, Boldin M, Natarajan R (2016) Anti-inflammatory role of MicroRNA-146a in the pathogenesis of diabetic nephropathy. J Am Soc Nephrol 27(8):2277–2288PubMedCrossRefGoogle Scholar
  4. Bryson CL (2003) Association between gestational diabetes and pregnancy-induced hypertension. Am J Epidemiol 158(12):1148–1153PubMedCrossRefGoogle Scholar
  5. Chen DB, Wang W (2013) Human placental microRNAs and preeclampsia. Biol Reprod 88(5):130PubMedPubMedCentralCrossRefGoogle Scholar
  6. Chiofalo B, Laganà AS, Vaiarelli A, La Rosa VL, Rossetti D, Palmara V, Valenti G, Rapisarda AMC, Granese R, Sapia F, Triolo O, Vitale SG (2017) Do miRNAs play a role in fetal growth restriction? A fresh look to a busy corner. Biomed Res Int 2017:6073167PubMedPubMedCentralCrossRefGoogle Scholar
  7. Cornelis T, Odutayo A, Keunen J, Hladunewich M (2011) The kidney in normal pregnancy and preeclampsia. Semin Nephrol 31(1):4–14PubMedCrossRefGoogle Scholar
  8. Dai Y, Jia P, Fang Y, Liu H, Jiao X, He JC, Ding X (2016) miR-146a is essential for lipopolysaccharide (LPS)-induced cross-tolerance against kidney ischemia/reperfusion injury in mice. Sci Rep 6:27091PubMedPubMedCentralCrossRefGoogle Scholar
  9. Desir GV (2011) Role of renalase in the regulation of blood pressure and the renal dopamine system. Curr Opin Nephrol Hypertens 20(1):31–36PubMedCrossRefGoogle Scholar
  10. Devier DJ, Lovera JF, Lukiw W (2015) Increase in NF-κB-sensitive miRNA-146a and miRNA-155 in multiple sclerosis (MS) and pro-inflammatory neurodegeneration. Front Mol Neurosci 8:5PubMedPubMedCentralCrossRefGoogle Scholar
  11. Dziedzic M, Powrózek T, Orłowska E, Koch W, Kukula-Koch W, Gaweł K, Bednarek-Skublewska A, Małecka-Massalska T, Milanowski J, Petkowicz B, Solski J (2017) Relationship between microRNA-146a expression and plasma renalase levels in hemodialyzed patients. PLoS ONE 12(6):e0179218PubMedPubMedCentralCrossRefGoogle Scholar
  12. English FA, Kenny LC, McCarthy FP (2015) Risk factors and effective management of preeclampsia. Integr Blood Press Control 8:7–12PubMedPubMedCentralGoogle Scholar
  13. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18(6):499–502PubMedGoogle Scholar
  14. Girling JC, Dow E, Smith JH (1997) Liver function tests in pre-eclampsia: importance of comparison with a reference range derived for normal pregnancy. Br J Obstet Gynaecol 104(2):246–250PubMedCrossRefGoogle Scholar
  15. Gohil JT, Patel PK, Gupta P (2011) Estimation of lipid profile in subjects of preeclampsia. J Obstet Gynaecol India 61(4):399–403PubMedPubMedCentralCrossRefGoogle Scholar
  16. Gomez-Lira M, Ferronato S, Orlandi E, Dal Molin A, Malerba G, Frigerio S, Rodolfo M, Romanelli MG (2015) Association of microRNA 146a polymorphism rs2910164 and the risk of melanoma in an Italian population. Exp Dermatol 24(10):794–795PubMedCrossRefGoogle Scholar
  17. Jensen LA, Chik CL, Ryan EA (2016) Review of gestational diabetes mellitus effects on vascular structure and function. Diabetes Vasc Dis Res 13(3):170–182CrossRefGoogle Scholar
  18. Koivusalo SB, Rönö K, Klemetti MM, Roine RP, Lindström J, Erkkola M, Kaaja RJ, Pöyhönen-Alho M, Tiitinen A, Huvinen E, Andersson S, Laivuori H, Valkama A, Meinilä J, Kautiainen H, Eriksson JG, Stach-Lempinen B (2016) Gestational Diabetes mellitus can be prevented by lifestyle intervention: the Finnish Gestational Diabetes Prevention Study (RADIEL): a randomized controlled trial. Diabetes Care 39(1):24–30PubMedCrossRefGoogle Scholar
  19. Laganà AS, Giordano D, Loddo S, Zoccali G, Vitale SG, Santamaria A, Buemi M, D’Anna R (2017) Decreased Endothelial Progenitor Cells (EPCs) and increased Natural Killer (NK) cells in peripheral blood as possible early markers of preeclampsia: a case–control analysis. Arch Gynecol Obstet 295(4):867–872PubMedCrossRefGoogle Scholar
  20. Laganà AS, Vitale SG, Sapia F, Valenti G, Corrado F, Padula F, Rapisarda AMC, D’Anna R (2018) miRNA expression for early diagnosis of preeclampsia onset: hope or hype? J Matern Fetal Neonatal Med 31(6):817–821PubMedCrossRefGoogle Scholar
  21. Lee J, Ouh YT, Ahn KH, Hong SC, Oh MJ, Kim HJ, Cho GJ (2017) Preeclampsia: a risk factor for gestational diabetes mellitus in subsequent pregnancy. PLoS ONE 12(5):e0178150PubMedPubMedCentralCrossRefGoogle Scholar
  22. Li XL, Chen TT, Dong X, Gou WL, Lau S, Stone P, Chen Q (2014) Early onset preeclampsia in subsequent pregnancies correlates with early onset preeclampsia in first pregnancy. Eur J Obstet Gynecol Reprod Biol 177:94–99PubMedCrossRefGoogle Scholar
  23. Mackay AP, Berg CJ, Atrash HK (2001) Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol 97:533–538PubMedGoogle Scholar
  24. Maharaj NR, Ramkaran P, Pillay S, Chuturgoon AA (2017) MicroRNA-146a rs2910164 is associated with severe preeclampsia in Black South African women on HAART. BMC Genet 18(1):5PubMedPubMedCentralCrossRefGoogle Scholar
  25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412–419PubMedCrossRefGoogle Scholar
  26. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111(5):649–658PubMedPubMedCentralCrossRefGoogle Scholar
  27. Mehanna ET, Ghattas MH, Mesbah NM, Saleh SM, Abo-Elmatty DM (2015) Association of microRNA-146a rs2910164 gene polymorphism with metabolic syndrome. Folia Biol (Praha) 61(1):43–48Google Scholar
  28. Moran P, Lindheimer MD, Davison JM (2004) The renal response to preeclampsia. Semin Nephrol 24(6):588–595PubMedCrossRefGoogle Scholar
  29. Munazza B, Raza N, Naureen A, Khan SA, Fatima F, Ayub M, Sulaman M (2011) Liver function tests in preeclampsia. J Ayub Med Coll Abbottabad 23(4):3–5PubMedGoogle Scholar
  30. Ostlund I, Haglund B, Hanson U (2004) Gestational diabetes and preeclampsia. Eur J Obstet Gynecol Reprod Biol 113(1):12–16PubMedCrossRefGoogle Scholar
  31. Paterson MR, Kriegel AJ (2017) MiR-146a/b: a family with shared seeds and different roots. Physiol Genom 49(4):243–252CrossRefGoogle Scholar
  32. Qu JY, Xi J, Zhang YH, Zhang CN, Song L, Song Y, Hui RT, Chen JZ (2016) Association of the microRNA-146a SNP rs2910164 with ischemic stroke incidence and prognosis in a Chinese Population. Int J Mol Sci 17(5):660PubMedCentralCrossRefGoogle Scholar
  33. Ramkaran P, Khan S, Phulukdaree A, Moodley D, Chuturgoon AA (2014) MiR-146a polymorphism influences levels of miR-146a, IRAK-1, and TRAF-6 in young patients with coronary artery disease. Cell Biochem Biophys 68:259–266PubMedCrossRefGoogle Scholar
  34. Redman CW, Sargent IL (2005) Latest advances in understanding preeclampsia. Science 308(5728):1592–1594PubMedPubMedCentralCrossRefGoogle Scholar
  35. Rong Y, Bao W, Shan Z, Liu J, Yu X, Xia S, Gao H, Wang X, Yao P, Hu FB, Liu L (2013) Increased microRNA-146a levels in plasma of patients with newly diagnosed type 2 diabetes mellitus. PLoS ONE 8(9):e73272PubMedPubMedCentralCrossRefGoogle Scholar
  36. Ryckman KK, Spracklen CN, Smith CJ, Robinson JG, Saftlas AF (2015) Maternal lipid levels during pregnancy and gestational diabetes: a systematic review and meta-analysis. BJOG 122(5):643–651PubMedCrossRefGoogle Scholar
  37. Schneider S, Freerksen N, Röhrig S, Hoeft B, Maul H (2012) Gestational diabetes and preeclampsia—similar risk factor profiles? Early Hum Dev 88(3):179–184PubMedCrossRefGoogle Scholar
  38. Siddiqui IA (2014) Maternal serum lipids in women with pre-eclampsia. Ann Med Health Sci Res 4(4):638–641PubMedPubMedCentralCrossRefGoogle Scholar
  39. van der Graaf AM, Toering TJ, Faas MM, Lely AT (2012) From preeclampsia to renal disease: a role of angiogenic factors and the renin-angiotensin aldosterone system? Nephrol Dial Transplant 27(Suppl 3):iii51–iii57PubMedGoogle Scholar
  40. Wagner LK (2004) Diagnosis and management of preeclampsia. Am Fam Physician 70(12):2317–2324PubMedGoogle Scholar
  41. Weissgerber TL, Mudd LM (2015) Preeclampsia and diabetes. Curr Diabetes Rep 15(3):579CrossRefGoogle Scholar
  42. Williams AE, Perry MM, Moschos SA, Larner-Svensson HM, Lindsay MA (2008) Role of miRNA-146a in the regulation of the innate immune response and cancer. Biochem Soc Trans 36(Pt 6):1211–1215PubMedCrossRefGoogle Scholar
  43. Wiznitzer A, Mayer A, Novack V, Sheiner E, Gilutz H, Malhotra A, Novack L (2009) Association of lipid levels during gestation with preeclampsia and gestational diabetes mellitus: a population-based study. Am J Obstet Gynecol 201(5):e1–e8CrossRefGoogle Scholar
  44. Xia ZG, Yin HF, Long Y, Cheng L, Yu LJ, Guo WJ, Zhu XD, Li J, Wang YN, Yang YJ, Wang JC, Jin L, Qiu LX, Wei Y (2016) Genetic variant of miR-146a rs2910164 C>G and gastric cancer susceptibility. Oncotarget 7(23):34316–34321PubMedPubMedCentralCrossRefGoogle Scholar
  45. Xiang Z, Song J, Zhou X, Li Q, Zhang X (2017) MiR-146a rs2910164 polymorphism and head and neck carcinoma risk: a meta-analysis based on 10 case–control studies. Oncotarget 8(1):1226–1233PubMedGoogle Scholar
  46. Yang K, He YS, Wang XQ, Lu L, Chen QJ, Liu J, Sun Z, Shen WF (2011) MiR-146a inhibits oxidized low-density lipoprotein-induced lipid accumulation and inflammatory response via targeting toll-like receptor 4. FEBS Lett 585(6):854–860PubMedCrossRefGoogle Scholar
  47. Yogev Y, Langer O, Brustman L, Rosenn B (2004) Pre-eclampsia and gestational diabetes mellitus: does a correlation exist early in pregnancy? J Matern Fetal Neonatal Med 15(1):39–43PubMedCrossRefGoogle Scholar
  48. Zeng Y, Sun Q, Liu N, Dong G, Chen J, Yang L, Wang B (2010) Correlation between pre-miR-146a C/G polymorphism and gastric cancer risk in Chinese population. World J Gastroenterol 16(28):3578–3583PubMedPubMedCentralCrossRefGoogle Scholar
  49. Zhang W, Yi X, Guo S, Shi Q, Wei C, Li X, Gao L, Wang G, Gao T, Wang L, Li C (2014) A single-nucleotide polymorphism of miR-146a and psoriasis: an association and functional study. J Cell Mol Med 18(11):2225–2234PubMedPubMedCentralCrossRefGoogle Scholar
  50. Zhong H, Cai Y, Cheng J, Cai D, Chen L, Su C, Li K, Chen P, Xu J, Cui L (2016) Apolipoprotein E epsilon 4 enhances the association between the rs2910164 polymorphism of miR-146a and risk of atherosclerotic cerebral infarction. J Atheroscler Thromb 23(7):819–829PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Biochemistry, Faculty of PharmacySuez Canal UniversityIsmailiaEgypt

Personalised recommendations